Brief: China Regenerative Medicine International enters MOU regarding proposed sale and purchase of cell and stem cell business

China Regenerative Medicine International

17/08/2016 11:47

Aug 17 (Reuters) - China Regenerative Medicine International Ltd  8158.HK : 
 * Crmi-joint announcement for the memorandum of understanding in relation to  the proposed sale and purchase of cell and stem cell business  8158.HK  
 * Says HKLST and CRMI entered into a Memorandum Of Understanding 
 * MOU in relation to proposed sale of certain companies engaged in cell and stem cell business held by CRMI group to HKLST 
 
 * Source text for Eikon  ID:nHKSccvtm7  
 
 * ((Further company coverage:  8158.HK )) 
   ((Bangalore.newsroom@thomsonreuters.com))